Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors.

Elaine M Langenfeld1, John Langenfeld

  • 1Department of Surgery, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ 08903-0019, USA.

Molecular Cancer Research : MCR
|March 24, 2004
PubMed
Summary

Bone Morphogenetic Protein-2 (BMP-2) drives tumor growth by promoting new blood vessel formation. Inhibiting BMP-2 reduces this cancer angiogenesis, offering potential therapeutic targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone morphogenetic protein receptor 2 signaling mediates mitochondrial Ca<sup>2+</sup> transport through its regulation of TAK1 splice variant.

Cell communication and signaling : CCS·2026
Same author

Clinical and Genomic Features and Prognostic Biomarkers of Oligometastatic Nonsmall Cell Lung Cancer.

Clinical lung cancer·2025
Same author

Treatment of Bronchopleural Fistulas in Coronavirus Disease 2019 With Coils, Glue, and an Amplatzer Vascular Plug.

Annals of thoracic surgery short reports·2025
Same author

BMP receptor 2 inhibition regulates mitochondrial bioenergetics to induce synergistic cell death with BCL-2 inhibitors in leukemia and NSLC cells.

Research square·2024
Same author

Locally Advanced Lung Cancer.

Hematology/oncology clinics of North America·2023
Same author

Ym155 localizes to the mitochondria leading to mitochondria dysfunction and activation of AMPK that inhibits BMP signaling in lung cancer cells.

Scientific reports·2022

Area of Science:

  • Oncology
  • Molecular Biology
  • Angiogenesis Research

Background:

  • Bone Morphogenetic Protein-2 (BMP-2) is overexpressed in lung carcinomas.
  • The precise role of BMP-2 in cancer progression remains unclear.
  • Understanding BMP-2's function is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the role of BMP-2 in tumor neovascularization.
  • To determine if BMP-2 enhances angiogenesis in lung cancer models.
  • To elucidate the molecular mechanisms underlying BMP-2-induced angiogenesis.

Main Methods:

  • Tumor xenograft models using A549 lung carcinoma cells in nude mice.
  • Matrigel plug assays to assess angiogenesis in vivo.
  • In vitro studies using human aortic endothelial cells (HAEC) and umbilical vein endothelial cells.

Related Experiment Videos

  • Analysis of signaling pathways including Smad 1/5/8 and ERK-1/2 phosphorylation, and Id1 expression.

    • Main Results:

    • Recombinant BMP-2 significantly increased blood vessel formation in tumors and Matrigel plugs.
    • The BMP-2 antagonist noggin blocked BMP-2-induced angiogenesis.
    • Antisense inhibition of BMP-2 reduced blood vessel formation.
    • BMP-2 stimulated endothelial cell proliferation, tube formation, and activation of key signaling pathways (Smad, ERK, Id1).

    Conclusions:

    • BMP-2 significantly enhances the angiogenic response in developing tumors.
    • BMP-2 promotes tumor neovascularization by directly activating endothelial cells.
    • These findings suggest BMP-2 is a key mediator of tumor angiogenesis and a potential therapeutic target in lung cancer.